男女性高爱潮免费视频

<rp id="ysdpw"><ruby id="ysdpw"></ruby></rp>

  • <dd id="ysdpw"><track id="ysdpw"></track></dd>
    <li id="ysdpw"><acronym id="ysdpw"></acronym></li>
    <tbody id="ysdpw"></tbody>

  • <em id="ysdpw"></em>

    <rp id="ysdpw"><ruby id="ysdpw"><u id="ysdpw"></u></ruby></rp>

    <tbody id="ysdpw"><track id="ysdpw"></track></tbody>

  • <rp id="ysdpw"><ruby id="ysdpw"></ruby></rp>

    SME Times is powered by   
    Search News
    Just in:   • Q1 results, global cues depress equity market  • US stocks rise after Fed keeps interest rates near zero  • PM discusses MSMEs issues, credit growth with banks, NBFCs  • RIL's consolidated net profit up 30.6% in Q1FY21  • Samsung reports solid earnings in Q2 on strong chip business 
    Last updated: 29 Jun, 2020  

    Tablet.9.Thmb.jpg Carlyle, Piramal Pharma sign agreement on 20% strategic growth investment

    Tablet.9.jpg
       Top Stories
    » PM discusses MSMEs issues, credit growth with banks, NBFCs
    » Rupee may remain stable on swelling forex reserves
    » SMEs, startups gear up for Amazon Prime Day
    » Gold prices rally on ETF inflow: WGC
    » India can be major agro products exporter: Report
    SME Times News Bureau | 29 Jun, 2020
    Diversified company Piramal Enterprises on Saturday said that it will integrate its pharma businesses into Piramal Pharma.

    Piramal Pharma will include Piramal Pharma Solutions, Piramal Critical Care, Consumer Products Division, PEL's investment in the joint venture with Allergan India and Convergence Chemicals.

    Further, the integrated entity will receive an estimated fresh equity capital worth around $490 million for a 20 per cent stake from global investment firm Carlyle Group's affiliated entity.

    The transaction values the 'Pharma Business' at an enterprise value (EV) of $2,775 million with an upside component of up to $360 million depending on the company's FY21 performance, the diversified company said.

    "Based on the EV (excluding the upside component), exchange rate and pharma net debt as on 31st March 2020, the estimated equity capital investment for Carlyle's 20 per cent stake in Piramal Pharma would amount to $490 million," the company said in a statement.

    "The final amount of equity investment will depend on the net debt, exchange rate and performance against the pre-agreed conditions at the time of closing of the deal."
     
    Print the Page
    Add to Favorite
     
    Share this on :
     

    Please comment on this story:
     
    Subject :
    Message:
    (Maximum 1500 characters)  Characters left 1500
    Your name:
     

     
      Customs Exchange Rates
    Currency Import Export
    US Dollar
    66.20
    64.50
    UK Pound
    87.50
    84.65
    Euro
    78.25
    75.65
    Japanese Yen 58.85 56.85
    As on 31 Jul, 2020
      Daily Poll
    COVID-19 has directly affected your business
     Yes
     No
     Can't say
      Commented Stories
    » Petrol, diesel prices unchanged for third day(1)
     
     
    About Us  |   Advertise with Us  
      Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
    Follow Us : Facebook Twitter
    男女性高爱潮免费视频
  • <dd id="ysdpw"><track id="ysdpw"></track></dd>
    <li id="ysdpw"><acronym id="ysdpw"></acronym></li>
    <tbody id="ysdpw"></tbody>

  • <em id="ysdpw"></em>

    <rp id="ysdpw"><ruby id="ysdpw"><u id="ysdpw"></u></ruby></rp>

    <tbody id="ysdpw"><track id="ysdpw"></track></tbody>